Reply to: "Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19"

Open Forum Infect Dis. 2020 Jul 29;7(8):ofaa321. doi: 10.1093/ofid/ofaa321. eCollection 2020 Aug.

Authors

Laura Ambra Nicolini¹, Malgorzata Mikulska^{1

2}, Alessio Signori³, Antonio Di Biagio^{1

2}, Federica Portunato^{1

4}, Antonio Vena¹, Mauro Giacomini⁵, Matteo Bassetti^{1

2}

Affiliations

¹ Infectious Diseases Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy.
² Department of Health Sciences, University of Genoa, Genoa, Italy.
³ Section of Biostatistics, Department of Health Sciences, University of Genoa, Genoa, Italy.
⁴ Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Caserta, Italy.
⁵ Department of Informatics, Bioengineering, Robotics and System Engineering, University of Genoa, Genoa, Italy.

No abstract available